Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
J Med Virol ; 93(12): 6837-6840, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34324212

RESUMEN

BACKGROUND: Gargle samples have been proposed as a noninvasive method for detection of SARS-CoV-2 RNA. The clinical performance of gargle specimens diluted in Cobas® PCR Media and in Cobas® Omni Lysis Reagent was compared to oropharyngeal/nasopharyngeal swab (ONPS) for the detection of SARS-CoV-2 RNA. STUDY DESIGN: Participants were recruited prospectively in two COVID-19 screening clinics. In addition to the ONPS, participants gargled with 5 ml of natural spring water split in the laboratory as follows: 1 ml was added to 4.3 ml of polymerase chain reaction (PCR) media and 400 µl was added to 200 µl of lysis buffer. Testing was performed with the Cobas® SARS-CoV-2 test on the Cobas® 6800 or 8800 platforms. RESULTS: Overall, 134/647 (20.7%) participants were considered infected because the ONPS or at least one gargle test was positive. ONPS had, respectively, a sensitivity of 96.3% (95% confidence interval [CI]: 91.3-98.5); both gargle processing methods were slightly less but equally sensitive (90.3% [95% CI: 83.9-94.3]). When ONPS and gargle specimens were both positive, the mean cycle threshold (Ct ) was significantly higher for gargles, suggesting lower viral loads. CONCLUSION: Gargle specimens directly added in PCR Media provide a similar clinical sensitivity to chemical lysis, both having a slightly, not significantly, lower sensitivity to ONPS.


Asunto(s)
Prueba de Ácido Nucleico para COVID-19/métodos , COVID-19/diagnóstico , COVID-19/virología , Nasofaringe/virología , Orofaringe/virología , SARS-CoV-2/genética , Pruebas Diagnósticas de Rutina/métodos , Humanos , Tamizaje Masivo/métodos , Estudios Prospectivos , ARN Viral/genética , Saliva/virología , Manejo de Especímenes/métodos , Carga Viral/genética
2.
Am J Infect Control ; 40(5): 470-3, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21885158

RESUMEN

In response to 2 reported cases of nosocomial legionellosis after anti-tumor necrosis factor (TNF) treatment, the environmental controls and testing facilities in a 221-bed acute care hospital were investigated. This investigation led to the implementation of a series of specific preventive measures adapted from protocols used to protect immunosuppressed patients. These 2 cases of legionellosis might be related to 2 concurrent events: treatment of hospitalized patients with anti-TNF drugs and secondary environmental changes related to major construction work. Patients undergoing anti-TNF treatment may be at increased risk for developing opportunistic infections during construction work, renovations, or water supply perturbations and require specific preventive measures.


Asunto(s)
Infección Hospitalaria/epidemiología , Factores Inmunológicos/efectos adversos , Legionelosis/epidemiología , Factor de Necrosis Tumoral alfa/efectos adversos , Adulto , Anciano , Infección Hospitalaria/prevención & control , Microbiología Ambiental , Femenino , Humanos , Huésped Inmunocomprometido , Factores Inmunológicos/administración & dosificación , Control de Infecciones/métodos , Legionelosis/prevención & control , Masculino , Persona de Mediana Edad , Factor de Necrosis Tumoral alfa/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA